Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma

Medical and Pediatric Oncology

Volumn 41, Issue 5, 2003, Pages 471-472

  Miyagi, Takashi ^a   Nagasaki, Akitoshi ^a   Nakazato, Tetsuro ^a   Hyakuna, Nobuyuki ^a   Takasu, Nobuyuki ^a   Masuda, Masato ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Acute lymphoblastic leukemia; Burkitt lymphoma; Chemo radiotherapy; Rhabdomyosarcoma; Secondary malignant neoplasm

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PIRARUBICIN; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; BONE MARROW BIOPSY; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; GENE REARRANGEMENT; GENETIC SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ONCOGENE C MYC; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SECOND CANCER; STEM CELL TRANSPLANTATION; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASMS, SECOND PRIMARY; RHABDOMYOSARCOMA; RISK ASSESSMENT; THORACIC NEOPLASMS; THORACOTOMY;

EID: 0141925862     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10414     Document Type: Conference Paper

References (11)

1. Pagano L, Pulsoni A, Mele L, et al. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy. Leuk Lymphoma 2000;39:465-475.
2. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in child: An update from the late effects study group. J Clin Oncol 1985;3:532-538.
3. Kaldor J. Second cancer following chemotherapy and radiotherapy. An epidemiological perspective. Acta Oncol 1990;29:647-655.
4. Geetha N, SreedeviAmma N, Kusumakumary P, et al. Acute lymphoblastic leukemia occurring as a second malignancy: Report a case and review of literature. Pediatr Hematol Oncol 1999;16:267-270.
5. Scaradavou A, Heller G, Sklar CA. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 1995;76:1860-1867.
6. Kaplinsky C, Fisch A, Cohen IJ, et al. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol 1992;20:229-231.
7. Megonigal MD, Rappaport EF, Jones DH, et al. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proc Natl Acad Sci 1997:94:11583-11588.
8. Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 1991;13:222-246.
9. Salloum E, Tallini G, Levy A, et al. Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer Invest 1996;14:527-533.
10. Ikeda T, Sato K, Yamashita T, et al. Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol 2001;115:69-71.
11. Diller L, Sexsmith E, Cottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995:95:1606-1611.